Research News and Research

RSS

Scientists discover new mechanisms by which RNA drugs can control gene activity

Small RNA-based nucleic acid drugs represent a promising new class of therapeutic agents for silencing abnormal or overactive disease-causing genes, and researchers have discovered new mechanisms by which RNA drugs can control gene activity.

3 Feb 2012

Study to determine causes and impact of hyperkyphosis

The Institute for Aging Research of Hebrew SeniorLife, an affiliate of Harvard Medical School, today announced that Dr. Lisa Samelson and the Institute were awarded a $2.7 million grant from the National Institute on Aging to conduct a five-year study to better understand the cause of hyperkyphosis, a condition that causes extreme forward curvature of the spine.

3 Feb 2012

Researchers identify fexinidazole as potential new therapy for visceral leishmaniasis

Researchers at the University of Dundee have identified fexinidazole as a possible, much-needed, new treatment for the parasitic disease visceral leishmaniasis.

3 Feb 2012

MannKind prices underwritten public offering of 31,250,000 units of common stock

MannKind Corporation today announced the pricing of an underwritten public offering of 31,250,000 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.6 of a share of its common stock.

3 Feb 2012

Anemia triples risk of dying within a year after having a stroke

Being anemic could more than triple your risk of dying within a year after having a stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012.

3 Feb 2012

Insurance news: Sen. Feinstein supports state review of rate increases; Anthem plans in Colo. and Conn. to pay extra for coordinated care

Sen. Dianne Feinstein announced she is supporting a ballot measure to give California regulators the power to approve health insurance rates. In other news, Blue Shield in California says it will cover an autism behavioral therapy and Anthem Blue Cross and Blue Shield plans in Colorado and Connecticut announce plans to pay doctors for coordinating care.

3 Feb 2012

Multiple DNA repair defect in monocytes

Scientists working with Professor Bernd Kaina of the Institute of Toxicology at the Medical Center of Johannes Gutenberg University Mainz have demonstrated for the first time that certain cells circulating in human blood - so-called monocytes - are extremely sensitive to reactive oxygen species (ROS).

3 Feb 2012

CSIS report examines protection of health care in armed, civil conflict

This report from the Center for Strategic & International Studies' Global Health Policy Center, titled "Protection of Health Care in Armed and Civil Conflict," examines how "action [last year] at the U.N. Security Council, the World Health Organization, and the U.S. Department of State, combined with a new campaign by the International Committee of the Red Cross and civil society mobilization, led to potential breakthroughs in three key dimensions of protection -- documentation, prevention, and accountability."

3 Feb 2012

Aging America creates demand for health professionals, strategies to meet it emerge

News outlets report on efforts to meet the nation's demand for health professionals -- whether in rural areas or in primary care specialties.

3 Feb 2012

BodyMedia sues BASIS Science over wearable body monitoring technology patent infringement

BodyMedia, Inc., the leader in wearable body monitors, announced today that it has filed a patent infringement suit against BASIS Science, Inc. in the U.S. Federal District Court in Delaware for willfully infringing BodyMedia's breakthrough patented wearable body monitoring devices and sensor fusion technology.

3 Feb 2012

Silver as effective as leading chemotherapy drugs

The internet is awash with stories of how silver can be used to treat cancer. Now, lab tests have shown that it is as effective as the leading chemotherapy drug - and may have fewer side-effects.

3 Feb 2012

Version of 'Goldilocks' gene could determine future treatment for TB patients

'Goldilocks' gene could determine best treatment for TB patients Tuberculosis patients may receive treatments in the future according to what version they have of a single 'Goldilocks' gene, says an international research team from Oxford University, King's College London, Vietnam and the USA.

3 Feb 2012

HHS essential benefits 'bulletin' draws tide of comments

As the official window of time allowed for groups to react to the Department of Health and Human Services essential benefits proposal closed, a variety of objections, concerns and common themes became clear.

3 Feb 2012

Nuvo launches Synera in the U.S.

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced the U. S. launch of Synera.

3 Feb 2012

Researchers caution against over-reliance on CNT in return-to-play decisions

A new study by researchers at Indiana University-Purdue University Columbus and Pace University is critical of the widespread use of computerized neuropsychological tests (CNT) in decisions regarding when athletes can return to play after suffering a concussion.

3 Feb 2012

Medicare Advantage enrollment climbs, premiums fall

Medicare Advantage enrollments have risen a bigger-than-expected 10 percent since this time last year as average premiums have fallen 7 percent, the Department of Health and Human Services disclosed Wednesday.

3 Feb 2012

Women better at parking than men – Study

The study by NCP examined the habits of 2,500 drivers using car park CCTV footage. It found that women were better at finding a space, aligning their vehicles to prepare to park, and were more centered when finally parked. They also note that when men drive with a female passenger they are more likely to “pose park” — in other words, try to impress his female companion — by choosing the smaller of two vacant spaces.

2 Feb 2012

$Heart burn drugs and hip fractures in postmenopausal women smokers: Study establishes link$

Heart burn drugs and hip fractures in postmenopausal women smokers: Study establishes link

A new study shows that postmenopausal women with a history of smoking who take heartburn drugs called proton pump inhibitors (PPIs) for two years or longer may be more likely to sustain a hip fracture. The risk rises with longer use say researchers. But the risk does disappear after women stop taking these drugs for two years. Further women who never smoked were not at increased risk for hip fracture even if they took PPIs regularly, the study showed. The new findings appear in the journal BMJ.

2 Feb 2012

Skin cells converted to brain cells without intermediate stem cell stage

Researchers from California have successfully converted mouse skin cells into cells which develop into the main components of the brain. The experiment, reported in Proceedings of the National Academy of Sciences, is notable because it skipped the middle “stem cell” stage in the process.

2 Feb 2012

Blood cell therapy works for nasopharyngeal cancer: Study

Scientists from the Queensland Institute of Medical Research have made a breakthrough in the treatment of throat cancer. The researchers have developed a therapy that uses a patient's blood to grow special white blood cells that recognize and fight infected cancer cells. The results of this study have been published in the journal Cancer Research.

2 Feb 2012

Research News and Research

Scientists discover new mechanisms by which RNA drugs can control gene activity

Study to determine causes and impact of hyperkyphosis

Researchers identify fexinidazole as potential new therapy for visceral leishmaniasis

MannKind prices underwritten public offering of 31,250,000 units of common stock

Anemia triples risk of dying within a year after having a stroke

Insurance news: Sen. Feinstein supports state review of rate increases; Anthem plans in Colo. and Conn. to pay extra for coordinated care

Multiple DNA repair defect in monocytes

CSIS report examines protection of health care in armed, civil conflict

Aging America creates demand for health professionals, strategies to meet it emerge

BodyMedia sues BASIS Science over wearable body monitoring technology patent infringement

Silver as effective as leading chemotherapy drugs

Version of 'Goldilocks' gene could determine future treatment for TB patients

HHS essential benefits 'bulletin' draws tide of comments

Nuvo launches Synera in the U.S.

Researchers caution against over-reliance on CNT in return-to-play decisions

Medicare Advantage enrollment climbs, premiums fall

Women better at parking than men – Study

Heart burn drugs and hip fractures in postmenopausal women smokers: Study establishes link

Skin cells converted to brain cells without intermediate stem cell stage

Blood cell therapy works for nasopharyngeal cancer: Study

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery